BUSINESS
Glenmark Pharma soars as its arm receives USFDA’s approval for Lacosamide Tablets
Glenmark Pharma is currently trading at Rs. 454.35, up by 10.45 points or 2.35% from its previous closing of Rs. 443.90 on the BSE. The scrip opened at…
glenmark pharma products
BUSINESS
Glenmark Pharma’s arm gets USFDA’s nod for Bisoprolol Fumarate and Hydrochlorothiazide Tablets
Glenmark Pharmaceuticals’ subsidiary — Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (USFDA)…